Gamma-Music Based Intervention for Mild Alzheimer's Disease
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Northeastern University
- Study ID
- NCT05984524
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 95 Years
- Healthy Volunteers
- Accepted
Interventions
- Gamma-Music Based Intervention — BEHAVIORALGamma or Control lights with Music-Based Intervention for 8 week period
Study Details
The study will test and refine a novel brain-stimulation tool using gamma-frequency lights coupled with self-selected music for a gamma-music-based intervention for participants with mild Alzheimer's Disease. Results will yield a gamma-stimulation protocol that reliably influences brain activity (Aim 1), is adaptive, motivating and rewarding to use (Aim 2), and will generate predictions as to who might benefit the most from gamma-MBI (Aim 3). By bridging the gap between neurostimulation and behavioral intervention by combining music therapy with gamma- band neurostimulation, the present project aims to find a sustainable intervention that delays the progression of AD.
Key Dates
- Start date
- Jul 1, 2022
- Status verified
- Oct 2023
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Gamma8-week music-based intervention with gamma lights
- Placebo Comparator: Control8-week music-based intervention with control lights
Primary Outcome Measure
EEG activity [ Time Frame: 1 hour ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northeastern University | Boston | Massachusetts | 02115 | Psyche Loui, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- Trial-Ready Cohort-Down Syndrome (TRC-DS)Recruiting · University of Southern California · Phoenix, Arizona
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide RibosideRecruiting · Mclean Hospital · Belmont, Massachusetts
- Assess Fibrin in Brains With AD/ADRDPHASE1/PHASE2 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts